MeasuPro Premium TENS Unit Replacement Pads, 4 TENS Unit Pads, CE, FDA Approved

MeasuPro Premium TENS Unit Replacement Pads, 4 TENS Unit Pads, CE, FDA Approved
  • INCLUDES – Each package includes a set of reusable electrode pads, 4 pads in total. Each individual pad comes with a lead wire
  • SELF ADHESIVE – TENS unit muscle stimulator replacement pads are coated with a high quality gel that is self-adhesive to the skin – no conductive gel needed. Pads are flexible and conform to your body to provide maximum pain relief. Easily apply to all muscle groups
  • FDA APPROVED – MeasuPro TENS-310 Tens Unit and replacement pads are FDA approved. Use daily for immediate relief from muscle pain and soreness
  • REUSABLE & RESEABALE – Coated with a long lasting gel, these durable replacement units can be used for multiple sessions. TENS pad should last about 20 uses, lifetime can be extended cleaning skin before use. Electrode pads come in resealable double packaging, four to a pack, to preserve pad life and prevent gel from drying out. To ensure maximum number of uses store item in air tight storage bags
  • SATISFACTION GUARANTEED – MeasuPro strives for a positive customer experience. Our customer service team is always available to answer any questions or address any concerns you may have regarding your TENS unit or TENS unit pads

Maximize Your Massage
Get the most from your muscle stimulator with the right electrode pads. MeasuPro TENS unit pads are coated with the highest quality gel to ensure easy application and long pad lifetime. Electrodes conform to the body making them easy apply to any muscle group for instant relief of stiff or sore muscles

Features
– Strong Self Adhesive
– Soft, Soothing Gel Coating
– Reusable
– Resalable Packaging
– Compatible with Most Electrical Massagers and Muscle Stimulators

TENS Unit Best Practices
1. 10-15 minutes for each treatment area
2. 1-2 times per day per area
3. Intensity and speed selections are based upon the level of your comfort

Lowest Price: £6.99
Buy from Amazon



Comments are closed.